Professor Marietta Iacucci
Prof Marietta Iacucci is a leading researcher in AI and a pioneer in ‘Endo-Omics’, which fuses endoscopic and histologic information with ‘multi-omics data' in Inflammatory Bowel Disease.
Prof Iacucci qualified in medicine at the University of Rome and obtained her PhD in 2009. She trained and did research in Germany, the United Kingdom, and Japan and previously held permanent faculty positions at the Universities of Calgary, Canada and Birmingham, UK. She was a key investigator at the National Institute of Health Research in Birmingham. She led transdisciplinary work that predicted disease courses and outcomes in colonic neoplasia and inflammatory bowel disease, bridging engineering, bioinformatics, and imaging/omics.
She has been nominated for leadership positions in multiple international organisations. She is a fellow of the American Society of Gastrointestinal Endoscopy. American Gastroenterological Association Fellow, a member of e-Learning Taskforce and research officer of Governing Board of the European Crohn’s and Colitis Organisation (ECCO), member of the International Inflammatory Bowel Disease Organisation (IOIBD), member of the Global Interventional Inflammatory Bowel Disease Group, sits on the ESGE advanced imaging in colorectal neoplasia guidelines committee and IBD quality improvement committee working group.She has delivered key plenary talks at prestigious international conferences such as the American Gastroenterology Association/ American Society of Gastrointestinal Endoscopy, International Organisation for Study of IBD, European Crohn’s and Colitis Organization and European Society of Gastrointestinal Endoscopy. Her goal is to drive transdisciplinary precision medicine research in IBD and colon cancer.
Prof Iacucci qualified in medicine at the University of Rome and obtained her PhD in 2009. She trained and did research in Germany, the United Kingdom, and Japan and previously held permanent faculty positions at the Universities of Calgary, Canada and Birmingham, UK. She was a key investigator at the National Institute of Health Research in Birmingham. She led transdisciplinary work that predicted disease courses and outcomes in colonic neoplasia and inflammatory bowel disease, bridging engineering, bioinformatics, and imaging/omics.
She has been nominated for leadership positions in multiple international organisations. She is a fellow of the American Society of Gastrointestinal Endoscopy. American Gastroenterological Association Fellow, a member of e-Learning Taskforce and research officer of Governing Board of the European Crohn’s and Colitis Organisation (ECCO), member of the International Inflammatory Bowel Disease Organisation (IOIBD), member of the Global Interventional Inflammatory Bowel Disease Group, sits on the ESGE advanced imaging in colorectal neoplasia guidelines committee and IBD quality improvement committee working group.She has delivered key plenary talks at prestigious international conferences such as the American Gastroenterology Association/ American Society of Gastrointestinal Endoscopy, International Organisation for Study of IBD, European Crohn’s and Colitis Organization and European Society of Gastrointestinal Endoscopy. Her goal is to drive transdisciplinary precision medicine research in IBD and colon cancer.